Ravinder Sandhu
Psychiatry · Southfield, MINPI 1023435179
Payments from drug & device makers
Across 114 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$350
- AbbVie$349
- Supernus Pharmaceuticals, Inc.$241
- Lundbeck LLC$226
- Sunovion Pharmaceuticals Inc.$219
- Takeda Pharmaceuticals U.S.A., Inc.$137
- plus $444 from 7 others
What the payments were for
- Food & beverage$1,966100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $350 |
| AbbVie | 22 | $349 |
| Supernus Pharmaceuticals, Inc. | 13 | $241 |
| Lundbeck LLC | 13 | $226 |
| Sunovion Pharmaceuticals Inc. | 12 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $137 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $130 |
| Neurocrine Biosciences, Inc. | 4 | $82 |
| Ironshore Pharmaceuticals Inc. | 4 | $79 |
| Corium, LLC | 8 | $68 |
| Alkermes, Inc. | 2 | $51 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Tris Pharma Inc | 1 | $14 |
How this compares
$1,966 in reported general payments places this provider in the 80th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $3,644 |
| Vilazodone Hcl | 25 | $1,539 |
| Trazodone Hcl | 130 | $915 |
| Sertraline Hcl | 112 | $738 |
| Divalproex Sodium ErDivalproex Sodium | 20 | $686 |
| Divalproex Sodium | 30 | $623 |
| Perphenazine | 12 | $596 |
| Bupropion XlBupropion Hcl | 35 | $510 |
| Duloxetine Hcl | 66 | $471 |
| Risperidone | 58 | $443 |
| Oxcarbazepine | 15 | $420 |
| Hydroxyzine Pamoate | 59 | $404 |
| Prazosin Hcl | 38 | $384 |
| Aripiprazole | 30 | $321 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $316 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Southfield
- William GuySouthfield$562K
- Farhad AmiriSouthfield$40K
- Andreas SidiropoulasDetroit$2.8M
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
- Brian MickeyAnn Arbor$490K
- Sagar ParikhAnn Arbor$331K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.